Information about Cassifarma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0727.381.719

VAT liability
Yes
Established
22-05-2019
Last balance sheet year
2025
Company size
Small 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Cassifarma

2025 2024 2023 2022
Income statement
Profit/Loss € 66,323 14% € 58,284 -13% € 66,622 24% € 53,840
Gross margin € 114,699 12% € 102,486 -13% € 118,210 17% € 100,611
Balance sheet
Balance sheet total € 942,826 0% € 945,614 1% € 936,027 1% € 922,934
Equity € 398,795 20% € 333,305 21% € 275,880 31% € 210,092
Debts € 544,031 -11% € 612,309 -7% € 660,147 -7% € 712,842

Publications from Cassifarma

Date Publication
08-08-2019 Miscellaneous (FR)
24-05-2019 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Cassifarma?
The VAT number of Cassifarma is BE 0727.381.719.
Wat is the PEPPOL ID of Cassifarma?
The PEPPOL ID of Cassifarma is 0208:0727381719. Log in or start a free trial to see the full overview.
When was Cassifarma founded?
Cassifarma was founded on 22-05-2019.
What is the address of Cassifarma?
The current registered office of Cassifarma is located at Familie de Bayostraat 55, 3000 Leuven.
When was the last time Cassifarma filed their annual financial statements?
The most recent financial statements of Cassifarma were filed on 28-07-2026.
How many employees does Cassifarma have?
There are currently no employees working at Cassifarma or no workforce information is available.
What is the annual turnover of Cassifarma?
At the time of its most recent financial statements, Cassifarma did not publish any turnover figures. Cassifarma reported a gross margin of €114,698.76.